Oregon Right to Life PAC Endorses Congressman Bentz for CD 2

Salem, OR—As the 2022 primary election approaches, Oregon Right to Life PAC is pleased to endorse Congressman Cliff Bentz for re-election. Rep. Bentz has been a dedicated pro-life advocate and a reliable vote receiving a 100% scorecard from the National Right to Life Committee and an A+ rating from the Susan B. Anthony List. “In […]

FDA Eliminates Chemical Abortion Safeguards for Women

Yesterday, the Food and Drug Administration (FDA) moved to weaken chemical abortion safeguards designed to protect women from complications or potential abusive circumstances. The new policy will allow for mail-order abortions without in-person medical supervision. Chemical abortion, often referred to as the abortion pill, RU-486, or Mifeprex, can be performed up to 11 weeks gestation. […]

Supreme Court Hears Arguments over Mississippi Abortion Ban

Today, the Supreme Court heard arguments in the Dobbs v. Jackson case. Dobbs debates whether states can ban second-trimester abortions before babies can survive outside their mothers’ wombs — a law Mississippi voters want. They passed the Gestational Age Act (HB 1510) in 2018, forbidding abortions after 15 weeks of gestation. Though a lower court […]

ORTL Launches $100k Ad Campaign

Yesterday, Oregon Right to Life (ORTL) launched a digital ad campaign to highlight the urgent need to update abortion law in light of science. The campaign is timely as on December 1, the Supreme Court is set to take up a high-profile abortion lawsuit called Dobbs v. Jackson Women’s Health Organization. The lawsuit was a response […]

500% Increase in ER Visits Post-Chemical Abortions

As the Food and Drug Administration (FDA) works toward a December 16 decision on chemical abortion safeguards, a groundbreaking new study from Charlotte Lozier Institute (CLI) shows that increased access to abortion pills creates a significant public health risk. The rate of abortion-related emergency room visits following a chemical abortion increased over 500% from 2002 […]